PTPN22 and triple-A syndrome: In the current study, we used a comprehensive bioinformatics-based analysis and experimental validation to verify the gene encoding protein tyrosine phosphatase non-receptor type 22 (PTPN22) as a potentially specific biomarker for patients with AAA.